Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,861 | 8,677 | 10,742 | 6,504 | 9,055 |
| TOTAL | $7,908 | $9,897 | $12,219 | $8,387 | $10,887 |
| Non-Current Assets | |||||
| PPE Net | 3 | N/A | N/A | N/A | N/A |
| Intangibles | 0 | 0 | 0 | 0 | 7,465 |
| Other Non-Current Assets | 173 | 193 | 213 | 233 | 253 |
| TOTAL | $175 | $193 | $213 | $233 | $7,718 |
| Total Assets | $8,083 | $10,090 | $12,432 | $8,620 | $18,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 346 | 239 | 317 | 328 | 311 |
| Accrued Expenses | 202 | 312 | 1,574 | 403 | 216 |
| Other current liabilities | 195 | 189 | 189 | 189 | 589 |
| TOTAL | $826 | $821 | $2,161 | $999 | $1,193 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 89 | 109 | 129 | 151 | 172 |
| TOTAL | $89 | $109 | $129 | $151 | $172 |
| Total Liabilities | $915 | $931 | $2,290 | $1,149 | $1,364 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49 | 49 | 49 | 49 | 32 |
| Common Shares | 3 | 3 | 3 | 0 | 2 |
| Retained earnings | -72,964 | -70,882 | -68,270 | -64,248 | -51,235 |
| Other shareholders' equity | -300 | -300 | -300 | -300 | -300 |
| TOTAL | $7,168 | $9,160 | $10,142 | $7,471 | $17,240 |
| Total Liabilities And Equity | $8,083 | $10,090 | $12,433 | $8,620 | $18,604 |